95656-73-8 Usage
Chemical structure
The compound contains a cyclobutyl group, an ethanol group, an amino group, a cyano group, and a phenyl group.
Potential applications
It has potential applications in the pharmaceutical industry due to its possible interactions with biological receptors.
Research and development
It may be used in the research and development of new drug compounds.
Further investigation
Its specific properties and potential uses would need to be further investigated and studied to fully understand its potential applications.
Molecular weight
The molecular weight of the compound is approximately 222.3 g/mol.
Appearance
The compound is likely to be a solid or a liquid, depending on its purity and the conditions it is stored in.
Solubility
The compound's solubility in water or other solvents is not specified in the material provided.
Stability
The stability of the compound under different conditions (e.g., temperature, pH, light exposure) is not specified in the material provided.
Safety
The safety profile of the compound, including potential hazards and precautions for handling, is not specified in the material provided.
Check Digit Verification of cas no
The CAS Registry Mumber 95656-73-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,6,5 and 6 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 95656-73:
(7*9)+(6*5)+(5*6)+(4*5)+(3*6)+(2*7)+(1*3)=178
178 % 10 = 8
So 95656-73-8 is a valid CAS Registry Number.
95656-73-8Relevant academic research and scientific papers
BRONCHOSPASMOLYTIC 1-(P-AMINO-PHENYL)-2-AMINO-ETHANOLS-(1) AND SALTS
-
, (2008/06/13)
Racemic and optically active compounds of the formula wherein R1 is hydrogen, fluorine, chlorine, bromine, iodine or cyano, R2 is fluorine, trifluoromethyl, nitro or cyano, and R3 is alkyl of 3 to 5 carbon atoms, hydroxy(alkyl of 3 to 5 carbon atoms), cycloalkyl of 3 to 5 carbon atoms, 1-(3,4-methylenedioxy-phenyl)-2-propyl or 1-(p-hydroxy-phenyl)-2-propyl, and non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as analgesics, uterospasmolytics, bronchospasmolytics and antispastics for the skeletal musculature, and especially as beta 2-receptor mimetics and beta 1-receptor blockers
